Trademarkia Logo

Australia

AU$
XERIJECT
Protected: Registered/protected

Last updated on 18 Mar 2025

Owner Info

Xeris Pharmaceuticals, Inc.

180 N LaSalle Street, Suite 1810

Chicago IL 60601, UNITED STATES OF AMERICA

Serial Number

2531241 filed on 31 Dec 1969

Correspondent

Spruson & Ferguson

GPO Box 3898,

Sydney, NSW, 2001 AUSTRALIA,

XERIJECT

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of diseases and conditions, namely, alimentary tract, metabolic, oncologic, autoimmune, and nervous syst Read More

Mark Details


Serial Number

2531241

Registered On

3 Jun 2021

Renewal On

3 Jun 2031

Mark Type

WORD

Priority Claim (Convention Details)


Date

4 Dec 2020

Mark Type

US

Legal History


Status DateAction Taken
18th Mar 2025General Correspondence sent
18th Mar 2025IP right goods and service classes updated
18th Mar 2025IP Right Goods and Services Items updated
18th Mar 2025Owner name details updated